Synergistic effects of melatonin and deprenyl against MPTP-induced mitochondrial damage and DA depletion.
about
Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor SymptomsSelective CCK-A but not CCK-B receptor antagonists inhibit HT-29 cell proliferation: synergism with pharmacological levels of melatoninMelatonin combats molecular terrorism at the mitochondrial level.Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence.Melatonin attenuates MPTP-induced neurotoxicity via preventing CDK5-mediated autophagy and SNCA/α-synuclein aggregation.Mitochondrial DNA and inflammatory diseases.Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: is it all set to irrefutable clinical translation?Extrapineal melatonin: sources, regulation, and potential functions.Melatonin protects SK-N-SH neuroblastoma cells from amphetamine-induced neurotoxicity.Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthasesMechanisms of N-methyl-D-aspartate receptor inhibition by melatonin in the rat striatum.Melatonin and the electron transport chain.Melatonin protects against MPTP/MPP+ -induced mitochondrial DNA oxidative damage in vivo and in vitro.Melatonin rescues zebrafish embryos from the parkinsonian phenotype restoring the parkin/PINK1/DJ-1/MUL1 network.Dietary amelioration of locomotor, neurotransmitter and mitochondrial aging.Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model.Melatonin is protective against 6-hydroxydopamine-induced oxidative stress in a hemiparkinsonian rat model.Coenzyme Q10 Prevents Mitochondrial Dysfunction and Facilitates Pharmacological Activity of Atorvastatin in 6-OHDA Induced Dopaminergic Toxicity in Rats.Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.Melatonin synergizes with low doses of L-DOPA to improve dendritic spine density in the mouse striatum in experimental Parkinsonism.Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease.
P2860
Q28075345-0164CF8F-7964-430A-8730-D45D3EBFA82DQ28271296-1FB9BA1A-D2BB-4AAE-A80F-365A29F818B6Q34359618-46F00C97-7AF1-4971-ACAB-4FDD04851581Q36582757-6266D89B-E1C7-4C3D-9F59-71242E660F62Q36777303-DA3CA0A6-A79A-41B9-81E2-9BF287C7CCBAQ37898562-895648BC-D41D-4DD4-A440-2AA6D98C6402Q37971339-E75C5BD0-4C87-4ABC-BF24-0596BF54A533Q38189699-59BF7B0C-AAC7-4555-AE1B-4B7ACD05ED8DQ40110666-1F99437A-C7F0-4F33-A82F-0AC73A8302C6Q41363567-EF03561C-3D95-4D01-8D55-8B5346FEEF31Q45177776-B5AA8C8E-D07A-4414-AA9D-F7ADB935C791Q46324395-CFB0AE8E-9137-4C90-8D7E-547F4865BD5CQ46566152-3EA71647-DFEC-48FC-B95B-C9D0FF0E68F4Q46967068-2193F977-0885-45E1-ABE6-D53061CE84C2Q48216539-DD800BF0-AF5A-4C40-A789-D21CBBE815FAQ48248905-A95975AB-1D68-4E80-BFBB-3799DF25FAE3Q48271852-769F28DE-57F3-4549-8D01-5AD827280789Q48335945-B421594F-3387-4986-A9BB-A57911CFD6A8Q48357495-3E0AD638-5054-4565-9EA5-2DC6FA63F354Q49149998-38780C3F-B1DD-43E4-B66C-C132D5E458ACQ55048859-03DB4754-F2F9-44E3-849A-CC1842B9F61A
P2860
Synergistic effects of melatonin and deprenyl against MPTP-induced mitochondrial damage and DA depletion.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Synergistic effects of melaton ...... drial damage and DA depletion.
@en
Synergistic effects of melaton ...... drial damage and DA depletion.
@nl
type
label
Synergistic effects of melaton ...... drial damage and DA depletion.
@en
Synergistic effects of melaton ...... drial damage and DA depletion.
@nl
prefLabel
Synergistic effects of melaton ...... drial damage and DA depletion.
@en
Synergistic effects of melaton ...... drial damage and DA depletion.
@nl
P50
P1476
Synergistic effects of melaton ...... drial damage and DA depletion.
@en
P2093
Josefa León
Leila Bikjdaouene
P304
P356
10.1016/S0197-4580(02)00133-1
P577
2003-05-01T00:00:00Z